← All stocks

Xeris Biopharma Holdings, Inc.

XERS Scheduled selling only
CIK 0001867096 #2214 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$311.24K
$311.24K on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 3 sales
Net
−$311.24K
$0.00 against sales at will

By person

14 insiders · 3 transactions
33.1×

John Shannon holds 33.1 times base salary in stock. $24.64M of shares against $742.33K in salary for 2025.

Salary from the company's own proxy. The shares are what John Shannon last reported holding, valued at $8.50, the price Common Stock was last bought or sold at on the open market here, on 1 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Hecht Beth
See Remarks
$141.43K (1) scheduled
−$141.43K
1,127,796
0.6186%
$9.59M
−18.9%
McCulloch Kevin
See Remarks
$127.31K (1) scheduled
−$127.31K
1,664,208
0.9128%
$14.15M
+1.4%
Pieper Steven
See Remarks
$42.50K (1) scheduled
−$42.50K
1,356,053
0.7438%
$11.53M
−4.8%
Shannon John Patrick Jr
See Remarks
2,898,933
1.59%
$24.64M
+34.5%
JOHNSON JOHN
Director
707,276
0.3879%
$6.01M
−20.6%
Nguyen Anh Tu
See Remarks
395,023
0.2167%
$3.36M
+30.4%
JOHNSON KENNETH ERLAND
See Remarks
320,446
0.1758%
$2.72M
−14.4%
Kong Garheng
Director
238,337
0.1307%
$2.03M
+45.2%
SHERMAN JEFFREY W
Director
219,188
0.1202%
$1.86M
+33.3%
PERSKY MARLA
Director
150,693
0.0827%
$1.28M
+40.2%
BORMANN-KENNEDY BARBARA-JEAN ANNE
Director
150,693
0.0827%
$1.28M
+40.2%
HALKUFF DAWN
Director
119,193
0.0654%
$1.01M
+10.9%
Brady James Aloysius
Director
113,359
0.0622%
$963.55K
KREHER NERISSA
Director
33,582
0.0184%
$285.45K
Insider
Date
Role
Action
Shares
Price
Amount
Pieper Steven
1 Sep 2026
See Remarks
Sold on a plan
5,000
$8.50
$42.50K
Hecht Beth
1 Sep 2026
See Remarks
Sold on a plan
16,666
$8.49
$141.43K
McCulloch Kevin
1 Sep 2026
See Remarks
Sold on a plan
15,000
$8.49
$127.31K

What was left out

Form 4 filings counted 5
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 3
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 5 Oct 2021